In the KA-induced epilepsy model, compared with control mice, Sh2d5-KO mice exhibited a prolonged latency to seizure onset and SE onset in the acute phase after KA administration (Figure 2, F and G). The gene discussed is SH2D5; the disease is epilepsy.